Literature DB >> 8077210

Inducible expression and cellular localization of insulin-degrading enzyme in a stably transfected cell line.

W L Kuo1, B D Gehm, M R Rosner, W Li, G Keller.   

Abstract

Insulin degrading enzyme (IDE) is an evolutionarily conserved, nonlysosomal metalloprotease that has been implicated in the cellular degradation and processing of insulin. However, the site and the mode of the action of this enzyme are unclear. We have addressed these questions by establishing several Ltk- cell lines that can overexpress human insulin-degrading enzyme (hIDE) upon glucocorticoid induction. The level of overexpression of hIDE protein and transcripts in these lines correlates well with an increase in insulin degradation in both cell lysates and intact cells. Comparison of the deduced amino acid sequences of mammalian and Drosophila IDEs reveals a conserved carboxyl-terminal peroxisomal targeting sequence (A/S-K-L), suggesting that IDE may be localized in peroxisomes. To test this possibility, we determined the cellular location of the stably transfected hIDE by both immunofluorescence and immunocryoelectron microscopy. The overexpressed hIDE predominantly colocalized with catalase in peroxisomes, although IDE was also found in the cytosol at a much lower concentration. These results demonstrate that stably transfected IDE catalyzes a rate-limiting step in cellular insulin degradation and is localized predominantly in peroxisomes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8077210

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

1.  Purified recombinant insulin-degrading enzyme degrades amyloid beta-protein but does not promote its oligomerization.

Authors:  V Chesneau; K Vekrellis; M R Rosner; D J Selkoe
Journal:  Biochem J       Date:  2000-10-15       Impact factor: 3.857

Review 2.  Gluconeogenesis and the peroxisome.

Authors:  C Masters
Journal:  Mol Cell Biochem       Date:  1997-01       Impact factor: 3.396

3.  Age-associated, oxidatively modified proteins: A critical evaluation.

Authors:  S Goto; A Nakamura
Journal:  Age (Omaha)       Date:  1997-04

4.  Neurons regulate extracellular levels of amyloid beta-protein via proteolysis by insulin-degrading enzyme.

Authors:  K Vekrellis; Z Ye; W Q Qiu; D Walsh; D Hartley; V Chesneau; M R Rosner; D J Selkoe
Journal:  J Neurosci       Date:  2000-03-01       Impact factor: 6.167

5.  Uptake and metabolic fate of [HisA8,HisB4,GluB10,HisB27]insulin in rat liver in vivo.

Authors:  F Authier; G M Di Guglielmo; G M Danielsen; J J Bergeron
Journal:  Biochem J       Date:  1998-06-01       Impact factor: 3.857

6.  Association of insulin-degrading enzyme with a 70 kDa cytosolic protein in hepatoma cells.

Authors:  F Authier; P H Cameron; V Taupin
Journal:  Biochem J       Date:  1996-10-01       Impact factor: 3.857

7.  Inositol phosphates and phosphoinositides activate insulin-degrading enzyme, while phosphoinositides also mediate binding to endosomes.

Authors:  Eun Suk Song; HyeIn Jang; Hou-Fu Guo; Maria A Juliano; Luiz Juliano; Andrew J Morris; Emilia Galperin; David W Rodgers; Louis B Hersh
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-21       Impact factor: 11.205

8.  Insulin-degrading enzyme in a human colon adenocarcinoma cell line (Caco-2).

Authors:  J P Bai; M J Hsu; W T Shier
Journal:  Pharm Res       Date:  1995-04       Impact factor: 4.200

Review 9.  Mechanisms of Abeta clearance and catabolism.

Authors:  Suzanne Y Guénette
Journal:  Neuromolecular Med       Date:  2003       Impact factor: 3.843

10.  Differential cerebral deposition of IDE and NEP in sporadic and familial Alzheimer's disease.

Authors:  Verónica Berta Dorfman; Laura Pasquini; Miguel Riudavets; Juan José López-Costa; Andrés Villegas; Juan Carlos Troncoso; Francisco Lopera; Eduardo Miguel Castaño; Laura Morelli
Journal:  Neurobiol Aging       Date:  2008-11-18       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.